Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-31

Clinical Trial Update: Transcranial Photobiomodulation With Near-Infrared Light for Language in Individuals With Down Syndrome [NA]

View source ↗

Summary

This clinical trial update describes a study on transcranial photobiomodulation with near-infrared light aimed at improving language in individuals with Down sy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Down Syndrome | NA | Status: ACTIVE_NOT_RECRUITING